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Glomerular permeability to neutral and anionic dextrans in
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The glomerular filtration of macromolecules such as proteins
is dependent upon their size, charge and structure, as well as
the pore size and electrostatic properties of the glomerular
filtration barrier [1—4]. In addition, renal hemodynamic factors
may influence the clearance of macromolecules [5—91. In pa-
tients with recent onset insulin-dependent diabetes mellitus
(IDDM), an increase in glomerular filtration rate (GFR) is well
documented [10—131. At this time, urinary excretion of albumin
is sometimes greater than normal [14—16] and precedes the
appearance of nonselective proteinuria and glomerular sclerosis
by many years. In experimental diabetes mellitus, an increase
in urinary albumin excretion has also been demonstrated [17—
19]. In both human IDDM and experimental diabetes mellitus it
is possible that this increased urinary albumin excretion is a
result of hemodynamic alterations and/or changes in the func-
tional characteristics of the filtration barrier.
The clearance of a polydispersed population of neutral and
anionic dextrans was measured to evaluate the influence that
experimental diabetes mellitus may have on the hemodynamic
and structural determinants of the glomerular filtration of
macromolecules. Two variations of alloxan-induced diabetes in
the rat were evaluated: untreated diabetes and insulin-supple-
mented diabetes mellitus. Depressed renal function was ob-
served after 3 months of untreated diabetes and included
decreases in both superficial nephron GFR and plasma flow
without evidence of intravascular volume depletion [20]. In
contrast, after 3 months of insulin-supplemented diabetes,
superficial nephron GFR and plasma flow were increased.
These two diabetic models were used to evaluate the permeabil-
ity of the glomerular filtration barrier to neutral and anionic
dextrans.
Methods
Induction of diabetes and experimental design. Diabetes was
induced in nonfasted, pentobarbital anesthetized Sprague-Daw-
Icy rats (Charles River, Wilmington, Massachusetts) weighing
175 to 250 g each. Alloxan monohydrate (5,6-Dioxyuracil,
Sigma Chemical Co., St. Louis, Missouri) in 0.9% sodium
chloride was injected into the inferior vena cava (50 to 55 mg/kg
of body wt). Renal vessels were clamped for 5 mm at the time of
injection to protect kidneys from alloxan damage [21]. Age-
matched control rats underwent the same surgical procedure
but received 0.9% sodium chloride intravenously. Rats with
nonfasting serum glucose concentrations above 250 mg/dl were
classified as diabetic. All rats were fed a normal rat chow diet
(Ralston Purina Co., St. Louis, Missouri) and allowed ad
libitum drinking water up to the time of the experiment.
Because it has been demonstrated previously that insulin
supplementation produces pronounced effects on renal function
in diabetic rats [20], two groups of diabetic rats were studied: 12
rats after 3 months of untreated diabetes (D3) and 11 rats after 3
months of insulin-supplemented (6 U of NPH insulin, 4 P.M.
daily s.c.) diabetes (Dm3). Twelve age-matched SHAM-operat-
ed rats served as controls (C3).
Functional measurements. All rats were placed in individual
metabolic cages for 24-hr urine collections to determine glu-
cose, albumin, and total protein excretions. Approximately 1
week later, rats were anesthetized with sodium pentobarbital
(30 to 50 mg/kg of body weight) and placed on a heated board to
maintain body temperature at 36.5 to 37.5° C. Surgical prepara-
tion included a tracheostomy, cannulation of both jugular veins
(PE6O) and cannulation of the left femoral artery (PE1O) in order
to monitor mean arterial pressure (MAP) with a strain gage
pressure transducer and a digital display amplifier system. A
PE5O catheter was placed in the bladder. Micropuncture mea-
surements were performed prior to the determination of dextran
and dextran sulfate clearances. The results of micropuncture
studies were presented in a previous report [20].
Glomerular filtration of either neutral or anionic dextrans was
assessed using an infusion of 0.45% sodium chloride containing
one of the two dextran types and 0.0008 mCi/ml of '4C-carboxy-
inulin (New England Nuclear, Boston, Massachusetts) at 0.5
mllhr/lOO g of body weight. Blood was withdrawn for glucose
determination and 45 mm were allowed for the rat to stabilize.
Urine collection periods lasted 15 to 30 mm and blood samples
(0.3 ml) were withdrawn at the beginning, the middle, and the
end of the collection period. Blood sampling times were cor-
rected for the delay in tubule to urine transit time by lissamine
green injections.
C3 and D3 groups were equally divided for infusions of either
neutral (ND-6 rats) or anionic (DS-6 rats) dextrans. In the Dm3
groups, six rats received ND infusion and five rats received DS
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infusion. Validation of ND and DS as filtration markers was
performed in four normal rats. The tubule fluid to the plasma
concentration ratio of the dextran divided by the same ratio for
inulin concentration deviated on the average only 3% from the
urine to plasma ratio of dextran divided by that for inulin. This
indicates that no significant secretion or reabsorption of dex-
trans occurred in the nephron [5, 6].
Equal volumes of plasma samples were mixed together for
subsequent analyses. Urine volumes were determined gravi-
metrically and radioactivity of plasma and urine samples was
determined using standard scintillation techniques.
Preparation of dextrans. Neutral (ND) and anionic (DS)
dextrans were prepared from dextrans Tb, T40 and dextran
sulfate (Pharmacia, Piscataway, New Jersey) using modified
procedures of Chang et al [5]. DS was prepared from manufac-
tured dextran sulfate (500,000 daltons) by dissolving 1 g of DS in
18 ml of water and adding 2 ml of 1 N hydrochloric acid, then
heating the DS to approximately 100° C for 10 mm to partially
hydrolyze the dextran sulfate.
Tritiation of ND or DS was performed using the oxidation/re-
duction method described by Chang et al [5]. Briefly, ND (equal
parts TlO and T40) or DS were oxidized with sodium periodate
in water for 8 hr in the dark. After desalting, reduction was
carried out with tritiated sodium borohydride (New England
Nuclear, Boston, Massachusetts) in water at pH 8.0 for 6 hr.
The manufacturer reports DS to have an average of 2.3
sulfate units per monomeric dextran residue unit. An indepen-
dent assay (Gaibraith Lab., Inc., Knoxville, Tennessee) indi-
cated the presence of 2.0 sulfate units per residue. However,
preparative hydrolysis cleaved much of the sulfate from the DS
molecules and diminished the content to about 1.0 sulfate unit
per dextran residue (Galbraith Lab.). Nonetheless, nearly all
the DS remained significantly negatively charged as determined
by anion exchange chromatography using diethylaminoethyl
cellulose (DE52-Whatman Ltd., Maidstone, Kent, United
Kingdom).
Column chromatography. Fractionation of plasma and urine
samples was performed using a G 100 Sephadex (Pharmacia,
Piscataway, New Jersey) column of 34 ml bed volume and 55
cm in length. The eluant was 0.3% sodium chloride with 0.02%
sodium azide; eluted fractions were collected with a Beckman
automatic fraction collector. Blue dextran (10 mg/mI) was used
to determine the void volume (V0); the fraction volume avail-
able to the solute (KAy) was then calculated:
KAy = (Ve — V0)/(V1 — V0)
where Ve is the elution volume of the solute and V1 is the total
bed volume of the gel column. A 250-hi portion of each
chromatographic fraction was counted by standard liquid scin-
tillation techniques to determine 3H-dextran concentration.
The column was calibrated using dextrans TlO and T40 with
molecular weights averaging 10,400 and 43,500, respectively,
and calculated Stokes-Einstein molecular radii of 23.7 and 46.4
A, respectively, determined from the data of Granath and Kvist
[22]. Column calibration was performed at least once a month
or when V0 appeared significantly altered. The calibration of
the column using neutral dextrans may overestimate the
Stokes-Einstein radius for dextran sulfate molecules due to
differences in configuration (that is, less uncoiling of dextran
sulfate). However, this potential systematic error should not
affect relative differences determined between groups of rats for
the filtration of dextran sulfate molecules.
Chemical analyses. Plasma glucose concentration was deter-
mined by the glucose hexokinase method on an Abbott Bichro-
matic analyzer (Abbott Laboratories, South Pasadena, Califor-
nia). Urinary protein concentration was determined by the
biuret technique [23]. Urinary albumin concentration was deter-
mined by the single radial immunodiffusion technique using
monospecific rabbit antibody to rat albumin [24, 25] with
purified rat albumin as the standard [17]. Protein and albumin
excretion rates are expressed as mg/24 hr. Nonradiolabelled
dextrans used in column calibration were assayed by the
anthrone method [26].
Calculations. The fractional clearance relative to inulin (0)
for ND or DS at a given molecular radius was calculated using
the urine to plasma ratio (U/P) of activities for either ND or DS
at the appropriate radius (that is, chromatographic fraction) and
the U/P for inulin:
°ND = (U/P)ND/(U/P)IflIfl and 0DS = (U/P)Ds/(U/P)LfllI
The clearances of inulin (CIN), neutral dextran (CND) or
dextran sulphate (CDS) were derived from the urine flow rate
(V) and the following equations: CIN = V(U/P)ij1; CND =
V(U/P)ND; CDS = V(U/P)Ds.
Pore theory—mathematical model. A pore theory model of
neutral macromolecular transport across glomerular capillary
walls has been presented by Chang et al [27] and further
modified by Deen, Bohrer, and Brenner [28]. In the present
study, an idealized glomerular capillary was arbitrarily divided
axially into 50 equal segments. Equations 1 and 2, shown
below, describe the volume (J) and solute (J) flux equations
for each segment. These equations were solved sequentially
and summed over the entire capillary length. The solute flux
(equation 2) is comprised of both a diffusive component and a
convective or solvent drag component. Material balances for
protein and solute are given in equations 3 and 4, respectively.
The fractional clearance for the solute was calculated using
equation 5. The filtration barrier characteristics (that is, pore
radius, r, and the ratio of total pore area to pore length, S '/1) are
related to the ultrafiltration coefficient (Kf) by equation 6.
These calculations were performed with the aid of a Hewlett-
Packard model 9845A computer.
J./' (for segment n) = Kf (P — H) 50 (1)
for Kf, glomerular ultrafiltration coefficient (that is, surface area
x hydraulic permeability); P, net hydraulic filtration pressure
(glomerular capillary pressure minus Bowman's space pres-
sure); and H, capillary plasma colloid osmotic pressure as
calculated from the Landis-Pappenheimer relationship:
H (mmHg) = 2.1 Cp + 0.16 Cp2 + 0.009 Cp3
where Cp is total plasma protein concentration in g/dl.
Jfl (for segment n) = F (C — CB) + WC,. J' (2)
Diffusion Convection
for F = Kf 8HD/r2 50
C,, = (CB — Ce)/(l — e0°) — (C — CB)an
= (W/HD) r 50/Kf 8
where is viscosity of water at 37° C; D, Fick's Law diffusivity
of solute; C, CB, concentration of solute in plasma (C,,) and in
Bowman's space (CB); r, pore radius; H,W, coefficients ex-
pressing the retarding effects of pore walls. H and W are
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Table 1. Superficial nephron functiona
Group N
GPF
nI/mm
P
mm Hg
Cp
gidI
Kf
nl/sec/mmHg FF
C3:3 month control 12 162 39.9 5.4 0.070 0.31
D3:3 months untreated
diabetes 12 119 34.5 5.1 0.075 0.35
D1n3:3 months insulin-
supplemented diabetes 11 201 40.5 5.6 0.075 0.31
a Data are summarized from reference 20. Abbreviations are: GPF, glomerular plasma flow; P, net hydraulic filtration pressure; Cp, arterial
protein concentration; Kf, ultrafiltration coefficient; FF, filtration fraction.
Table 2. General characteristics of diabetic ratsa
functions only of the ratio of solute to pore radius. These values
are taken from the numerical results of Paine and Scherr [291.
Cp' (for segment n+ 1) =
C' (for segment n+l) =
where GPF is glomerular capillary plasma flow.
o =
Kf = (S'/l) (r2/8x)
The necessary measurements which allow prediction of 0's
from equations I to 5 have been obtained by micropuncture
techniques from the rats of this study. These results are
presented elsewhere as part of a more extensive evaluation of
glomerular hemodynamics in diabetic rats [20] and values for
the pertinent variables are summarized in Table 1.
Statistical analysis. Where applicable, data are expressed as
mean SEM. Data from control and experimental groups were
compared using either the paired or unpaired Student's t test
with a P value <0.05 considered to be significant.
Results
The general characteristics of diabetic rats are summarized in
Table 2. D3 rats grew poorly and had significantly lower body
weights than C3 rats although kidney weights were similar in
the two groups. In contrast, Dm3 rats grew normally and had
significantly larger kidneys than C3 rats. GFR was decreased
11% in D3 rats and increased 20% in Dm3 rats. Total protein
(3) excretions were increased 34% in both groups of diabetic rats
(4) but were not significantly different from the control value.
Albumin excretion rates were also increased in D3 rats (164%)
and in Dm3 rats (35%) but only that in D3 rats was significantly
different from the control value.
Neutral dextran clearances. In D3 rats, the fractional clear-
ance of neutral dextran (OND) was significantly increased be-
tween 32 and 36 A radii (Table 3, Fig, 1) while the absolute
clearance of neutral dextran (CND) at these sizes was unaltered
due to the offsetting decline in GFR. At smaller molecular radii
(20 to 24 A), CND was reduced as a result of the fall in GFR.
Insulin-supplemented diabetic rats (Dm3) had no significant
alteration in °ND but CND increased significantly between 28
and 42 A (Table 3, Fig. 1) as a result of the increased GFR in
Dm3 rats.
Anionic dextran sulfate clearances. D3 rats had significantly
reduced °DS up to 36 A molecular radius and reduced CDS up to
a molecular radius of 32 A (Table 3, Fig. 2). Dm3 rats also had a
significantly reduced ODS. CDS was decreased, but this did not
reach statistical significance due to the increased GFR in Dm3
rats. Thus, both groups of diabetic rats demonstrated increased
restriction to the transglomerular passage of anionic
macromolecules.
Group N
Plasma
glucose
mg/dl
Arterial
pH
BW
g
LKW
g
GFRb
mi/mm
Excretion
Glucose Albumin
mg/24 hr
Protein
C3:3 month control 12 147 7.42
0.02
541
32
1.65
0.07
1.77
0.09
6
2
0.14
0.04
15.5
2.5
D3:3 months untreated
diabetes 12 528 7.45
0.02
349
17
1.71
0.09
1.57
0.11
8800
1700
0.37
0.06
20.8
4.1
P value
D3 vs. C3 0.001 NS 0.02 NS NS 0.001 0.01 NS
D1n3:3 months insulin
supplemented
diabetes 11 412 7.45
0.02
555
12
1.94
0.10
2.13
0.10
990
440
0.19
0.05
20.7
2.9
P value
Dm3 vs. C3 0.001 NS NS NS 0.02 0.00! NS NS
Dm3 vs. D3 NS NS 0.001 NS 0.01 0.001 0.05 NS
a Values are expressed mean SEM. Abbreviations are NS, P value greater than 0.05; BW, body
glomerular filtration rate.
b GFR expressed per single kidney.
weight; LKW, left kidney weight; GFR,
(5)
(6)
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Table 3. Fractional clearance of neutral (OND) and anionic (ODS) dextransa
Group N
Dextran radius in Angstroms
20 24 28 32 36 40 44 48
°ND
C3 6 0.980
0.012
0.365
0.011
0.139
0.023
0.048
0.003
0.011
0.002
D3 6 0.993 0.984
0.020
0.886
0.030
0.698
0.020
0.409
0.016
0.184
0.020
0.067
0.018
0.018
0.010
P-C3 vs. D3 NS NS NS 0.05 0.05 NS NS NS
predictedb 1.00 0.98 0.89 0.69 0.43 0.18 0.069 0.029
Dm3 6 1.011 0.980
0.023
0.857
0.023
0.608
0.010
0.357
0.011
0.174
0.013
0.065
0.015
0.026
0.011
P-C3 vs. Dm3 NS NS NS NS NS NS NS NS
predicted 1.00 0.98 0.85 0.62 0.32 0.17 0.068 0.028
°DS
C3 6 0.607 0.423
0.066
0.254
0.053
0.143
0.029
0.0713
0.0179
0.0255
0.0119
0.0056
0.0031
0.0007
0.0003
D3 6 0.390 0.196
0.053
0.099
0.031
0.057
0.018
0.0258
0.0056
0.0047
0.0006
0.0007
0.0001
0.0002
0.0001
P-C3 vs. D3 0.05 0.05 0.05 0.05 0.05 NS NS NS
Dm3 5 0.429 0.196
0.042
0.099
0.021
0.067
0.015
0.0354
0.0060
0.0074
0.0011
0.0008
0.0001
0.0002
0.0001
P-C3 vs. Dm3 NS 0.02 0.02 0.05 NS NS NS NS
a Values are expressed mean ScM; NS, P value > 0.05.
See text.
Discussion
Morphological and functional studies have demonstrated that
the glomerular capillary wall acts as a charge-selective as well
as a size-selective barrier to the filtration of macromolecules [1,
2, 6, 71. To assess the effects of diabetes on the size-selective
properties of the filtration barrier, neutral dextran clearances
and an isoporous model of neutral macromolecular transport
represented by equations 1 and 2 were used for a single segment
of glomerular capillary (see Methods). Equation 2 describes the
flux of solute across the capillary wall which is comprised of
both diffusive and convective components. Transport of small
solutes is dominanted by convection and that of large solutes by
diffusion. In the rat, molecule transport between 28 to 38 A radii
is influenced significantly by both convection and diffusion. It
has been shown experimentally that the determinants of
glomerular filtration (GPF, Kf, zP and Cp) may influence
macromolecular transport by affecting either convective or
diffusive fluxes [5, 8, 30, 31]. The pore theory model combines
hemodynamic and permeability data to provide further insight
to the characteristics of the filtration barrier (that is, rand S'I1).
Under numerous physiological and pathophysiological circum-
stances in the rat, the model has been useful in predicting
whether or not alterations in macromolecular clearances are
more likely caused by changes in the filtration barrier or by
hemodynamic changes [5—8, 30, 31].
Results in the present study in untreated diabetic rats (D3)
demonstrate only a small increase in the fractional clearance of
neutral dextran and no change in the absolute clearance.
Diabetic rats with insulin supplementation (Dm3) had normal
fractional and supranormal absolute clearances of neutral dex-
trans. Superficial nephron functional data (Table 1) for both rat
groups were obtained prior to macromolecular clearance mea-
surements. These data, previously reported [20], were utilized
in the calculation of filtration barrier characteristics using
equations 1 to 6. The present study indicates that both rand S'/l
are functions of dextran size and that a single pore size does not
completely characterize the filtration barrier for all sizes of
dextran (Fig. 3). However, for a molecular radius greater than
38 A, where diffusion rather than convection dominates the
transglomerular passage of macromolecules, a uniform r of 55
to 60 A and S'/l of 8 to 10cm characterize the filtration barrier.
These results are similar to those determined in normal Munich-
Wistar rats [5, 311. In untreated diabetic rats, rand S'/l are not
different from control values regardless of dextran size (Fig. 3).
This indicates that the measured increase in °ND may be
explained solely on the basis of altered hemodynamics. Indeed,
in these untreated rats an increase in filtration fraction was
measured (Table 3) which would increase the capillary lumen
concentration of macromolecules and thereby enhance their
diffusion across the filtration barrier. In insulin-supplemented
rats, r, S'/l and filtration fraction were unchanged. 0ND was
also unchanged, an experimental result predicted by the mathe-
matical model. Hence, these data indicate that no detectable
alteration in the porosity or size-selectivity of the filtration
barrier was present in both untreated and insulin-supplemented
diabetic rats.
The clearance of anionic dextran sulfate in diabetic rats was
measured to assess the effect of diabetes on the charge-selective
properties of the filtration barrier. In both diabetic groups
anionic dextran clearance was reduced. This reduction oc-
curred despite the prediction that glomerular hemodynamics
should either increase (D3 rats) or not change (Dm3 rats)
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macromolecular transport across the filtration barrier. These
results imply that there is greater restriction to the passage of
anionic macromolecules (for example, albumin) across the
glomerular filtration barrier which may be a consequence of an
increased negative charge density in the filtration barrier sec-
ondary to compositional alterations of the glomerular basement
membrane. However, in both treated and untreated diabetic
rats, urinary protein excretion increased approximately 35%.
Urinary albumin excretion was also increased 35% in insulin-
supplemented rats but increased 164% in untreated rats. Thus,
an apparent discrepancy between reduced dextran sulfate clear-
ances and increased protein excretions exists suggesting that
factors other than charge-selectivity may be of major impor-
tance in determining protein filtration. In fact, the fractional
clearance of albumin is approximately two orders of magnitude
smaller [33, 34] than that for comparably sized DS molecules.
Indeed, a direct correlation between DS clearance data and the
filtration of albumin may be imprecise due to differences in
configuration, deformability, and surface charge density of
these two molecules [9, 32].
The mechanisms for the marked increase in albumin excre-
tion in D3 rats are not readily apparent but could include an
alteration in tubular protein reabsorption. Since the normal rat
filters and subsequently reabsorbs 50 to 100 mg of albumin per
day [33, 34], a 0.5% alteration in either filtration or reabsorption
could cause a three-fold change in albumin excretion. Although
tubular protein reabsorptive capacity could be exceeded during
high tubular flow rates such as those measured in D3 rats, this
E
001
20 24 28 32 36 40
Molecular radius, Angstroms
Fig. 2. Fractional (Os) and absolute (CDS) clearances of polydispersed
anionic dextran. Points represent means 5EM. P values are compared
to control. N = 6forgroupC3, N = 6forgroupD3,andN = 5forgroup
Dm3.
has not been found to be an important factor when studied
experimentally [35]. Alternatively, insulin itself could have a
direct affect on tubular reabsorption of protein [36]. In addition,
tubular protein reabsorption may be altered as a result of
structural abnormalities in proximal and distal tubules which
have been observed in untreated but not in insulin-supplement-
ed diabetic rats [18, 20].
In human IDDM, albuminuria may be evident early in the
course of the disease. Renal clearance data using neutral
dextrans, however, have been unable to explain this albumin-
uria on the basis of a glomerular defect in size-selectivity [11,
37, 38]. In IDDM patients (less than 12 years' duration), both an
increase in filtration fraction and an increase in GFR occur
which should theoretically combine to favor an increase in net
clearance of macromolecules such as albumin. Thus, some
investigators have proposed that hemodynamic alterations
alone may be responsible for increased albumin excretion in
diabetes [39, 40]. Data in the present study support clinical and
experimental [41] studies that demonstrate the absence of
significant size-selective defects of the glomerular filtration
barrier in diabetes and further suggest that an increase in the
charge-restrictive properties of this barrier may exist in
diabetes.
Summary. Renal clearances of polydispersed neutral and
anionic dextrans were measured in diabetic rats. In addition,
urinary protein and albumin excretion rates were determined.
0.6
0.5
0.40z
0z0
0.3
4
0.2
0.1
20 24 28 32 36 40 44
Molecular radius, Angstroms
48
Fig. 1.Fractional (ØND)and absolute (CDS) clearances of polydispersed
neutral dextran. Points represent means SEM. Pvalues are compared
to control. N = 6 for group C3, N = 6 forgroup D3, and N 6 for group
D1n3.
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Fig. 3. Pore radius (r) and pore area to length ratio (S'II)predictedfrom
an isoporous model of the glomerular filtration barrier. Points repre-
sent values predicted from mean data of neutral dextran fractional
clearances and nephron hemodynamics from Table 1.
Measurements were performed 3 months after the induction of
diabetes (i.v. alloxan 50 to 55 mg/kg of body wt) in rats which
were either untreated or which received supplemental insulin (6
U of NPH daily) and were compared to those in age-matched
SHAM-treated rats. Fractional clearances (relative to inulin) of
neutral dextrans remained unchanged in insulin-supplemented
rats and were slightly but significantly increased in untreated
rats. The application of an isoporous model of the glomerular
filtration barrier permitted the conclusion that the size-selective
characteristics of the barrier were unaltered in diabetic rats.
Fractional clearances of anionic dextrans were significantly
reduced 50 to 60% in both diabetic groups suggesting an
increase in the negative charge density of the filtration barrier
and potentially an increase in restriction to the glomerular
filtration of anionic proteins. However, urinary and albumin
excretions tended to increase in both groups of diabetic rats,
including a 164% increase in albumin excretion in untreated
rats. This apparent discrepancy between reduced dextran sul-
fate clearances and increased protein excretions suggests that
factors other than charge-selectivity may be of major impor-
tance in determining the filtration of proteins. The marked
increase in albumin excretion observed in our diabetic rats
appears to be a result of decreased tubular reabsorption rather
than increased filtration of albumin.
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